|
MAML1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.12700001845212E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.49880166242656E-11 |
| Normal-vs-Stage2 |
9.355400E-03 |
| Normal-vs-Stage3 |
7.69120000000401E-05 |
| Normal-vs-Stage4 |
1.812570E-04 |
| Stage1-vs-Stage2 |
1.587420E-01 |
| Stage1-vs-Stage3 |
3.909900E-02 |
| Stage1-vs-Stage4 |
9.230000E-02 |
| Stage2-vs-Stage3 |
9.686000E-01 |
| Stage2-vs-Stage4 |
8.758800E-01 |
| Stage3-vs-Stage4 |
8.738800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09240003101741E-09 |
| Normal-vs-AfricanAmerican |
1.419510E-03 |
| Normal-vs-Asian |
3.877800E-02 |
| Caucasian-vs-AfricanAmerican |
6.778200E-01 |
| Caucasian-vs-Asian |
1.860390E-01 |
| AfricanAmerican-vs-Asian |
4.089800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.64250000454092E-08 |
| Normal-vs-Female |
4.43839964781034E-10 |
| Male-vs-Female |
7.090100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.739700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.74870015637418E-10 |
| Normal-vs-Age(61-80Yrs) |
4.22369999975025E-07 |
| Normal-vs-Age(81-100Yrs) |
1.237590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.743400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.583000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.670200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.995800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.870000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.997000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.45959999999323E-05 |
| Normal-vs-Grade 2 |
4.10329548117261E-11 |
| Normal-vs-Grade 3 |
3.30189999997454E-06 |
| Normal-vs-Grade 4 |
8.784800E-03 |
| Grade 1-vs-Grade 2 |
8.961100E-03 |
| Grade 1-vs-Grade 3 |
4.0876000000023E-05 |
| Grade 1-vs-Grade 4 |
4.33050000003821E-06 |
| Grade 2-vs-Grade 3 |
7.920400E-03 |
| Grade 2-vs-Grade 4 |
1.875560E-03 |
| Grade 3-vs-Grade 4 |
2.935400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.03659311637239E-12 |
| Normal-vs-ccB subtype |
8.425100E-04 |
| ccA subtype-vs-ccB subtype |
9.68829999999921E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86640000010563E-07 |
| Normal-vs-N1 |
2.505000E-01 |
| N0-vs-N1 |
4.061200E-01 |
|
|
